IGFBP3 and Hyperglycemia: This dysbiosis leads to reduced levels of TUDCA and CARN, which in turn alleviate their inhibition on the synthesis of IGFBP-3 and the expression of IL-6, ultimately resulting in hyperglycemia and related vasculopathy.